Characterization of recurrent homogeneously staining regions in 72 breast carcinomas
Jacqueline Bernardino
Institut Curie, Paris, France
J. Bernardino is a fellow from the ARC.
Search for more papers by this authorCorresponding Author
Bernard Dutrillaux
Institut Curie, Paris, France
UMR 147 CNRS, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, FranceSearch for more papers by this authorJacqueline Bernardino
Institut Curie, Paris, France
J. Bernardino is a fellow from the ARC.
Search for more papers by this authorCorresponding Author
Bernard Dutrillaux
Institut Curie, Paris, France
UMR 147 CNRS, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, FranceSearch for more papers by this authorAbstract
Cytogenetic analyses were performed on 223 breast carcinomas, of which 60% contained homogeneously staining regions (hsr), an intrachromosomal cytogenetic feature of gene amplification. The precise hsr localization could be determined for 123 hsr from 72 cases. The juxtacentromeric region of chromosome 8, band 11q13, and the whole of chromosome 17 were frequently involved. For 28 cases, the origin of the DNA sequences forming HSR could be investigated by chromosome painting, comparative genomic hybridization, and/or Southern blotting. Sequences from chromosomes 11 and 17 were mostly found within hsr located on chromosomes 11 and 17, respectively. In contrast, sequences from chromosome 8 were rarely found within hsr localized on chromosome 8. These observations suggest that different mechanisms lead to hsr formation in breast cancer. Band 11q13 and the 17p chromosome arm may correspond to sites of in situ amplification driven by deletions distal to the amplification target genes. hsr in the region 17q2, which is also a frequent site of in situ amplification, takes place without the occurrence of a distal deletion. The short arm of chromosome 8 is often deleted, but frequently becomes the site of hsr formed elsewhere in the genome. Genes Chromosomes Cancer 23:100–108, 1998. © 1998 Wiley-Liss, Inc.
References
- Almeida A, Kokalj-Vokac N, Lefrancois D, Viégas-Péquignot E, Jeanpierre M, Dutrillaux B, Malfoy B (1993) Hypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines. Hum Genet 91: 538–546.
- Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemei OP, Trent JM, Meltzer PS (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965–968.
- Bernardino J, Gerbault-Seureau N, Zafrani B, De Rycke Y, Boudou E, Nagdelerat H, Dutrillaun B (1998) Homogeneously staining regions in 223 breast carcinomas cytogenetic and clinicopathological correlations. Br J Cancer (in press)
- Bièche I, Tomasetto C, Régnier CH, Moog-Lutz C, Rio MC, Lidereau R (1996) Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer. Cancer Res 56: 3886–3890.
- Brison O (1993) Gene amplification and tumor progression. Biochim Biophys Acta 1155: 25–41.
- Dib A, Adelaide J, Chaffanet M, Imbert A, Le Paslier D, Jacquemier J, Gaudray P, Theillet C, Birnbaum D, Pebusque MJ (1995) Characterization of the short arm of chromosome 8 amplified in breast carcinoma. Oncogene 10: 995–1001.
- Dutrillaux B, Gerbault-Seureau M, Zafrani B (1990) Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet 49: 203–217.
- Gebhart E, Brüderlein S, Augustus M, Siebert E, Feldner J, Schmidt W (1986) Cytogenetic studies on human breast carcinomas. Breast Cancer Res Treat 8: 125–138.
- Gerbault-Seureau M, Vielh P, Dutrillaux B (1987a) Recurrent hsr in the centromeric region of chromosome 8 in breast cancer. Ann Genet 30: 146–151.
- Gerbault-Seureau M, Vielh P, Zafrani B, Salmon R, Dutrillaux B (1987b) Cytogenetic study of twelve human near-diploid breast cancers with chromosomal changes. Ann Genet 30: 138–145.
- Guan XY, Meltzer PS, Dalton WS, Trent JM (1994) Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet 8: 155–161.
- Hui R, Campbell DH, Lee CSL, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R, Sutherland RL (1997) EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 1 1q 13 and may identify different phenotypes in primary breast cancer. Oncogene 15: 1617–1623.
- Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK, Waldman FM (1995) Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 147: 905–911.
- Isomura M, Tanigami A, Saito H, Harada Y, Katagiri T, Inazawa J, Ledbetter DH, Nakamura Y (1994) Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high-resolution physical map with 29 markers. Genes Chromosomes Cancer 9: 173–179.
- Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818–821.
- Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156–2160.
- Karlseder J, Zeillinger R, Schneeberger C, Czerwenka K, Speiser P, Ernst Kubista, Birnbaum D, Gaudray P, Theillet C (1994) Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 9: 42–48.
- Koreth J, Bakkenist CJ, McGee JO (1997) Allelic deletions at chromosome 11q22–q23.1 and 11q25–qterm are frequent in sporadic breast but not colorectal cancers. Oncogene 14: 431–437.
- Law DJ, Gebuhr T, Garvey N, Agulnik SI, Silver LM (1995) Identification, characterization, and localization to chromosome 17q21-22 of the human TBX2 homolog, member of a conserved developmental gene family. Mamm Genome 6: 793–797.
- Lemieux N, Dutrillaux B, Viegas-Péquignot E (1992) A simple method for simultaneous R- or G-banding and fluorescence in situ hybridization of small single-copy genes. Cytogenet Cell Genet 59: 311–312.
- Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronen-berg HM, Arnold A (1991) A novel cyclin encoded by a bcl1–linked candidate oncogene. Nature 350: 512–515.
- Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B (1994a) Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer 10: 160–170.
- Muleris M, Almeida A, Dutrillaux AM, Pruchon E, Vega F, Delattre JY, Poisson M, Malfoy B, Dutrillaux B (1994b) Oncogene amplification in human gliomas: A molecular cytogenetic analysis. Oncogene 9: 2717–2722.
- Nagai MA, Medeiros AC, Brentani RR, Marques LA, Mazoyer S, Mulligan LM (1995) Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology 52: 448–453.
- Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T (1985) Molecular structure of the human cytoplasmic beta-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82: 6133–6137.
- Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F (1992) Whole-arm t(1;16) and i(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer 5: 235–238.
- Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S (1995) Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12: 173–185.
-
Pandis N,
Bardi G,
Mitelman F,
Heim S
(1997)
Deletion of the short arm of chromosome 3 in breast tumors.
Genes Chromosomes Cancer
18:
241–245.
10.1002/(SICI)1098-2264(199704)18:4<241::AID-GCC1>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
-
Plummer SJ,
Paris MJ,
Myles J,
Tubbs R,
Crowe J,
Casey G
(1997)
Four regions of allelic imbalance on 17q12–qter associated with high-grade breast tumors.
Genes Chromosomes Cancer
20:
354–362.
10.1002/(SICI)1098-2264(199712)20:4<354::AID-GCC6>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schrock E, Latham C, Blegen H, Zetterberg A, Cremer T, Auer G (1995) Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 55: 5415–5423.
- Roelofs H, Tasseron-de Jong JG, van der Wal-Aker J, Rodenburg RJT, van Houten GBM, van de Putte P, Giphart-Gassler M (1992) Gene amplification in a human osteosarcoma cell line results in the persistence of the original chromosome and the formation of translocation chromosomes. Mutat Res 276: 241–260.
- Roelofs H, Schuuring E, Wiegant J, Michalides R, Giphart-Gassler M (1993) Amplification of the 11q13 region in human carcinoma cell lines: A mechanistic view. Genes Chromosomes Cancer 7: 74–84.
- Ruta M, Burgess W, Givol D, Epstein J, Neiger N, Kaplow J, Crumley G, Dionne C, Jaye M, Schlessinger J (1989) Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci USA 86: 8722–8726.
- Saint-Ruf C, Gerbault-Seureau M, Viegas-Péquignot E, Zafrani B, Malfoy B, Dutrillaux B (1991) Recurrent homogeneously staining regions in 8p1 in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes. Cancer Genet Cytogenet 52: 27–35.
- Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ (1992) Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7: 355–361.
- Steinarsdottir M, Petursdottir I, Snorradottir S, Eyfjord JE, Og-mundsdottir HM (1995) Cytogenetic studies of breast carcinomas: Different karyotypic profiles detected by direct harvesting and short-term culture. Genes Chromosomes Cancer 13: 239–248.
- Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo WL, Waldman M, Isola J, Gray JW, Kallioniemi OP (1994) Increased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes. Cancer Res 54: 4257–4260.
- Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjärvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer R Kallioniemi OP (1996) Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 56: 3441–3445.
- Toledo F, Buttin G, Debatisse M (1993) The origin of chromosome rearrangements at early stages of AMPD2 gene amplification in Chinese hamster cells. Curr Biol 3: 255–264.
- Tomasetto C, Régnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC (1995) Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11–q21.3 region of chromosome 17. Genomics 28: 367–376.
- Trent J, Yang JM, Emerson J, Dalton W, McGee D, Massey K, Thompson F, Villar H (1993) Clonal chromosome abnormalities in human breast carcinomas. II. Thirty-four cases with metastatic disease. Genes Chromosomes Cancer 7: 194–203.
- Wintersberger E (1994) DNA amplification: New insights into its mechanism. Chromosoma 103: 73–81.
-
Xu J,
Tyan T,
Cedrone E,
Savaraj N,
Wang N
(1996)
Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection.
Genes Chromosomes Cancer
17:
172–178.
10.1002/(SICI)1098-2264(199611)17:3<172::AID-GCC5>3.0.CO;2-1 CAS PubMed Web of Science® Google Scholar